Vildagliptin and Linagliptin Inhibit NLRP3 Pyroptosis in Diabetic Lungs
Diabetes mellitus (DM) is a multifactorial metabolic disorder characterized by hyperglycemia that induces damage across multiple organs, including the lungs. Recent evidence suggests that Nod-like receptor protein-3 (NLRP3)-mediated pyroptosis contributes significantly to diabetic complications.
Publication Details
- Journal
- Egyptian Society of Diabetes and Lipidology Journal
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21608/esdlj.2025.456301
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00